← Open Payments lookup

JOAO DE QUEVEDO: Open Payments

NPI 1205231008 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,214 in 55 payments from 14 companies in 2025. Trend: 2023 $30,608 · 2024 $2,867 · 2025 $2,214

Food & beverage: $2,214
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$788
Neurocrine BioSciences, Inc.6$339
LivaNova USA, Inc.5$276
Janssen Pharmaceuticals, Inc3$191
Janssen Scientific Affairs, LLC1$135
Otsuka America Pharmaceutical, Inc.4$91
Abbott Laboratories1$90
Axsome Therapeutics, Inc.1$54
Takeda Pharmaceuticals U.S.A., Inc.2$51
Teva Pharmaceuticals USA, Inc.2$47

Products named: CAPLYTA, SPRAVATO, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, INGREZZA, REXULTI, INFINITY, Auvelity, TRINTELLIX.

Industry payments across TX — which companies pay providers there.